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Abstract  
Background: Vitamin D Deficiency (VDD) is a public health concern worldwide. If untreated, it can 
lead to reduced quality of life and escalated costs brought about by ill-health. Preventive 
programmes to improve population vitamin D status exist but little is known about their the cost-
effectiveness. This information is vital so that decision-makers adopt efficient strategies and optimise 
use of public resources.      
Aims: Systematically review and critically appraise economic evaluations of population strategies to 
prevent VDD. 
Methods: The databases reviewed were MEDLINE, EMBASE, Econlit, NHS EED, CEA and RepEc. All full 
economic evaluations of VDD prevention strategies were included. Interventions considered were 
food fortification, supplementation and public health campaigns.  Data extracted included type of 
evaluation, population and setting, the measure of benefits and main results.  
Results: Of the 2492 records screened, 14 studies were included. The majority of studies focused on 
supplementation within at-risk groups with the primary objective of either preventing fractures or 
falls in older adults. There was insufficient economic evidence to draw conclusions about the cost-
effectiveness of population strategies. No study was identified that offered a direct comparison of 
the two main alternative population strategies: food fortification versus supplementation.    
Conclusion: Whilst there is a growing body of evidence on the cost-effectiveness of micro-nutrient 
programmes, there is a paucity of data on vitamin D fortification and how fortification programmes 
compare to population supplementation programmes.  We highlight research gaps, and offer 
suggestions of what is required to undertake population-based cost-effective analysis. 
Keywords: systematic review; vitamin D deficiency; public health; cost-effectiveness   
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Introduction  
Vitamin D deficiency (VDD) is associated with reduced intestinal absorption of calcium, leading to low 
bone mineralisation (rickets and osteomalacia), skeletal deformities, hypocalcaemic seizures, tetany 
and heart disease (1, 2). VDD can also manifest as musculoskeletal pain and weakness that may 
ultimately result in falls in the elderly population (3). A recent post-mortem study conducted in 
Germany found that the prevalence of undiagnosed osteomalacia was as high as 25% in the adult 
population (4). VDD affects populations worldwide and its prevention and improvement in 
nutritional status is a global public health priority, thereby ensuring optimal bone health in both 
children and adults (1, 5).  
The main source of Vitamin D is ultraviolet radiation (UV-B) containing sunlight, which prompts 
vitamin D production in the skin. VDD is therefore endemic in high latitude settings (>35⁰N) such as 
the UK (5), Canada (6), Belgium (7) and Scandinavia (5) where less UV-B sunlight is obtained 
throughout the year. Despite this geographical fact, VDD has predominantly been reported in low 
and mid latitudes (0⁰-35⁰), namely African and Asian countries, where cultural and dietary factors 
limit sunlight exposure and calcium intake (8). Vitamin D from sunlight or food sources is biologically 
inactive and needs to be converted in the human body, via two hydroxylation steps, into the 
hormone calcitriol (also called active vitamin D) whose function is to maintain healthy levels of 
calcium and phosphorus by increasing the intestinal absorption of those bone minerals (1). 
Therefore, Vitamin D is an indirect determinant of bone mineralization during childhood and 
adulthood. The best measure of vitamin D status is the also biologically inert 25 hydroxyvitamin D 
(25OHD), present in the blood serum.  The main risk factors for VDD include older age, dark skin 
pigmentation, and any barrier to UV-B light reaching the skin such as full body clothing, spending 
most time indoors, and air pollution (8). Because vitamin D is fundamental for healthy bone 
development and growth, optimal vitamin D intake is crucial in infants and young children, as well as 
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pregnant and breastfeeding women, and these populations are a common public health target, with 
the aim of avoiding irreversible consequences of severe VDD (9). 
Most countries have adopted public health policies to prevent VDD in at-risk groups of the 
population (10), opting for either 1) mandatory fortification of staple foods such as milk (Sweden and 
Finland) or voluntary fortification of breakfast cereals (UK) (10), or 2) supplementation programmes 
for pregnant and breastfeeding women, and infants (10).  Despite these initiatives, VDD still persists 
as a serious public health concern (5). A recent study conducted in Europe pooled estimates from 
55,844 individuals and found that VDD, defined as serum 25OHD concentrations below 30nmol/L, 
affects 13% of the European population (5). The evidence is robust about the much higher 
prevalence of VDD in dark-skinned populations, highlighting the inadequacy of the current policies in 
Europe to protect the at-risk groups (2, 5, 11). There has been continued research effort to 
determine a population strategy that is both clinically- and cost-effective. In November 2014, the 
UK’s National Institute for Health and Care Excellence (NICE) identified a lack of economic evidence 
to support vitamin D supplementation for certain groups of the population (12). In addition, in 2016 
the global consensus recommendations on the prevention and management of rickets highlighted 
the paucity of economic evaluation of rickets prevention strategies (8).  
This study aims to systematically review economic evaluations of VDD prevention and identify the 
evidence gaps to inform future research and public health policy.  
In addition, it aims to: 
 Determine the cost-effectiveness of population strategies; 
 Identify whether cost-effectiveness varies by population subgroup and country setting; 
 Identify and appraise alternative modelling structures for measuring the cost effectiveness of 
population strategies.  
 Determine the methods used for measuring the outcomes of strategies to prevent VDD (for 
example, death, quality-of-life, fractures, falls).  
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Methods Search Strategy 
This review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) methodology (13) where applicable.  Literature searches were conducted in January 2015 
and updated in April 2016. The search strategy included terms relating to VDD and health economics 
(full search strategy provided in the supplementary material). The following bibliographic databases 
were searched: MEDLINE, EMBASE, Econlit, NHS EED, CEA and RepEC. Additionally, the reference lists 
of the included articles were searched. The screening was conducted by the main reviewer (MA) and 
the second reviewer (EF) screened 10% of the titles and abstracts. Inclusion/exclusion criteria 
All full economic evaluations, defined as a consideration of both costs and outcomes together, were 
included namely cost-consequence, cost-effectiveness, cost-utility and cost-benefit analyses. The 
interventions of interest were those aiming to prevent VDD, including supplementation, food 
fortification and public health campaigns. Interventions were included if administering vitamin D 
alone, vitamin D in combination with calcium or multi-vitamin supplements containing vitamin D. 
There were no language restrictions.  Studies where VDD occurred as secondary to other health 
conditions, such as liver disease or malabsorption, were excluded. Data extraction  
The relevant characteristics of each study in relation to the methods used and main results were 
extracted. The data extracted included: population and setting; intervention and comparators; type 
of economic evaluation; analytical methods used; the perspective adopted; clinical outcomes and 
measure of benefits used; and the main results reported.  
Drummond’s checklist (14) was chosen to assess the quality of the included studies because it is a 
widely used quality tool that allows assessment of different types of economic evaluations including 
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cost-effectiveness, cost-utility and cost-benefit analysis, as well as any analytic method - model-
based and trial-based analysis, allowing us to use the same tool for all included studies. Studies were 
not excluded from the analysis on the basis of the quality assessment results, rather, the quality of 
the studies was considered when drawing conclusions from the synthesised data.  Data Synthesis 
First, the results were categorised by type of prevention strategy being evaluated. Second, the 
studies were grouped by type of intervention analysed. High heterogeneity was expected across 
studies due to the great variation in costs and resources used both between countries and within the 
same country. Therefore, pooled estimates were not considered appropriate to summarise the 
evidence.  
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Results   
Our search strategy generated 2492 references after duplicates were removed. All titles and 
abstracts were screened against the inclusion/exclusion criteria. Studies that were not economic 
evaluations, and/or did not evaluate strategies to prevent VDD were excluded. A total of 2466 were 
excluded and the primary reason for exclusion was not being a full economic evaluation. The 
remaining 26 full-text studies were examined and 14 studies were selected for data extraction, 9 
from the main search and 5 from the updated searches. A flowchart illustrating the study selection 
process is shown in Figure 1.  General characteristics of the included studies 
The identified studies spanned a period of 20 years, with the earliest being published in 1995 and the 
majority emerging between 2012 and 2016. Studies were carried out in the UK (15-19), the USA (20, 
21), Australia (22, 23), France (24), Finland (25), Sweden (26) and Germany (27). Additionally, there 
was one multi-country study that carried out cost-effectiveness analyses in seven European countries 
(28). The majority of studies (n=7) evaluated supplementation strategies of vitamin D alone in the 
adult population (16, 17, 20, 21, 23-25). Other studies investigated calcium and vitamin D 
interventions either through oral supplements (n=4) (15, 22, 26, 28) or food fortification (n=1) (27). 
One study evaluated interventions of supplementation with multi-vitamins that included vitamin D 
(19). Supplementation with vitamin D alone 
Eight studies evaluated interventions using supplements with vitamin D alone (16-18, 20-22, 24, 25) 
(Table 1) and all except one (18) focused on the elderly population. Five were cost-utility analyses 
using quality-adjusted life-years (QALYs) to measure benefits (16, 20, 21, 23, 24), two were cost-
effectiveness analyses (17, 25) and one was a cost-consequence analysis (18). Three studies 
compared universal supplementation against screening for VDD followed by supplementation (18, 
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21, 24), three studies evaluated vitamin supplements against interventions to prevent falls (20, 23, 
25) and two evaluated supplements against current care to prevent fractures (17) and falls (16) .  
Markov models were the preferred analytical method to simulate falls and fractures pathways (n=4) 
(16, 17, 21, 23). Screening and subsequent treatment was found to be more cost-effective than 
universal supplementation in the elderly population (21, 24), while universal supplementation was 
cost-saving when comparing to the screening alternative in the whole population (18). Interventions 
with vitamin D supplements in the elderly population were cost-effective when compared to current 
practice for the prevention of falls (16) and fractures (17), and when compared with multiple 
interventions for the prevention of falls (20, 23).  Supplementation with vitamin D and calcium 
Four economic evaluations focused on the prevention of VDD using supplements with a combination 
of vitamin D and calcium (Table 1) (15, 22, 26, 28). Two of them were cost-utility analyses using 
QALYs as a measure of benefit (22, 26) and two were cost-effectiveness analyses measuring the cost 
per ‘avoided fracture’ (15, 28).  Three studies (15, 26, 28) sourced the effectiveness data from a large 
French trial (29, 30) involving women in nursing homes. Two of these performed a trial-based 
analysis (15, 28) while another modelled the outcomes beyond the trial follow-up period through a 
Markov model (26). When compared with placebo, vitamin D and calcium were cost-effective in 
women aged 50 and 60 years (26) and cost-saving for at-risk women aged over 70-years-old in 
Sweden (26) and several other European countries (28). When compared with annual 
supplementation of high-dose vitamin D only (300 000 IU), the latter was found to be more cost-
effective (15).  
A different approach was used by Church and colleagues (22), who aimed to identify the most cost-
effective intervention to prevent falls by comparing multiple interventions, including vitamin D and 
calcium supplementation, as well as Tai-chi, medication reviews and multi-factorial approaches. Two 
different Markov models were used for the elderly population living in the community and in 
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residential aged care homes. Combined supplementation of vitamin D and calcium was one of the 
most cost-effective interventions for those living in residential aged care facilities (ICER AU$7,316), 
but not for those living in the community (22).  Supplementation with multi-vitamin preparation containing vitamin D 
One study evaluated an intervention using multi-vitamin supplements containing vitamin D (Table 2) 
(19).  Different schemes of universal and targeted supplementation strategies were compared and 
the effectiveness and outcomes measures were not limited to vitamin D but included folic acid and 
vitamin C for pregnant and breastfeeding women and vitamin A and C for infants and young children. 
(19). The results were largely driven by the effect of folic acid in pregnant women, due to the lack of 
effectiveness data for the other micronutrients, including vitamin D. Food fortification with vitamin D and calcium 
One study evaluated food fortification with vitamin D and calcium to prevent fractures in elderly 
women in Germany (Table 3) (27). It was a cost-effectiveness analysis comparing no fortification, 
which is the current German policy, with voluntary bread fortification.  The analysis used a 
fortification model based on the German population’s bread consumption (31). Effectiveness data on 
the fracture risk reduction was based on a Cochrane review of the effectiveness of vitamin D and 
calcium supplements (32). The authors found the intervention was cost-saving (27). Quality Assessment 
All papers reported the type of economic evaluation, described the alternatives being analysed and 
adequately drew conclusions from the results, although none of the studies fulfilled all the checklist’s 
requirements (full results provided in supplementary material). There was a general lack of rigour in 
reporting the methods, and the model inputs and assumptions. Most studies failed to provide 
justification for key methodological choices such as the time horizon, the analytical approach and the 
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discount rates chosen. There was also limited discussion about the sources of effectiveness data and 
how these affected the generalizability of the results.  
 Discussion  
This systematic review provides the first synthesis of the economic evidence on the prevention of 
population VDD. The review demonstrates that economic evaluation of interventions to prevent VDD 
is an expanding area of research, with 5 of the 14 included studies being published in 2015.  Despite 
the increasing number of studies, the evidence is still limited and does not address the main 
questions important to policy makers when considering the introduction of VDD prevention 
strategies. From the literature, it is not possible to determine the total costs of population strategies, 
nor the most cost-effective population strategy to prevent VDD and its consequences. Vitamin D is a 
relatively cheap compound and the literature favour interventions using it, particularly to prevent 
heavy-burden clinical outcomes, such as fracture in the elderly. The effectiveness of vitamin D and 
the incidence of falls were  important driver of results. 
We highlight below the main strengths and limitations of the currently available evidence and 
provide recommendations for future research.  Population 
The majority of the economic evaluations focused on the elderly population living in Western 
countries, highlighting a dearth of studies in all other at-risk groups:  infants and children, pregnant 
women, lactating women and ethnic minorities, as well as populations living in other geographical 
areas, in particular those with high prevalence of rickets.  
Severe symptomatic VDD has been reported in dark skinned infants, namely rickets, cardiomyopathy 
and seizures (2, 9).  This review found only one study which attempted an economic sub-group 
analysis focusing on dark skinned adult populations but results were limited by the paucity of 
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evidence to support the analysis (18).  Despite this, the study showed that, when the incidence of 
VDD increased, so did the probability of supplementation being cost-effective for that population 
(18). This suggests that interventions that are not cost-effective for the whole population may be 
cost-effective for at-risk groups, reinforcing the need for sub-group analysis by risk.   Type of economic evaluation and analytic approaches 
The majority of the studies performed cost-effectiveness (n=6) and cost-utility (n=7) analyses, with a 
focus on health and social care costs and outcomes. The holistic nature of population-based nutrition 
interventions which can lead to non-health care costs and benefits suggests that an alternative 
method of economic evaluation such as cost-benefit analysis may be more appropriate. This is 
important as the costs of nutrition interventions are likely to involve public health authorities and 
other public sectors, food consumers and the food industry. At the same time, the health benefits of 
population nutrition interventions can be far reaching, for instance, better childhood development 
will improve productivity in later years.  
Regarding the analytical methods used, six studies presented decision models, all Markov models, 
simulating the prevention of fractures (17, 26) or falls (16, 21-23). Markov models are appropriate as 
they enable long-term programmes to be modelled and account for recurrence.  VDD and its 
complications are dynamic health states, where patients transit from being deficient to being 
sufficient (i.e. seasonally). This transition is determined by exposure to risk factors, including sunlight 
exposure, age, and vitamin D and calcium intake from food and supplements, which vary with time 
and external factors. Interventions 
Thirteen of the fourteen included studies evaluated supplements with vitamin D, and different 
supplementation programmes were considered, all in the elderly. The majority of the studies 
evaluated oral supplements (n=12) (15-23, 25, 26, 28) while one analysed high-dose parenteral 
supplementation (24). The comparators varied  and included exercise (25), screening followed by 
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treatment (18, 21, 24), multi-interventions to prevent falls (20, 22, 23), parenteral vitamin D 
supplementation (15) and no intervention (16, 17, 26, 28). Only one study evaluated food 
fortification (27). 
Most of the interventions compared targeted a specific group of the population and aimed to 
prevent one clinical outcome related to VDD. The results are likely to not apply to population based 
scenarios. For instance, two studies evaluating screening programmes versus supplementation in 
older adults concluded that screening would be more cost-effective than providing supplements, 
particularly to elderly aged over 70 years and those at high-risk of fractures (21, 24). But the one 
study comparing the same intervention in the whole population found contrasting results, 
concluding that it is unlikely that universal vitamin D screening would be superior to universal 
supplementation at population level (18).  
There is a lack of studies evaluating population-based programmes. The only two studies that 
undertook broader analyses in several at-risks groups in the UK’s population (18, 19) highlight serious 
limitations due to the evidence gaps to support such analyses.   
Evaluation of combined strategies to prevent VDD has not yet been undertaken. Similarly to what the 
literature reports for other micronutrients (33, 34), the preferred public health approach to improve 
the nutritional vitamin D status of the whole population is likely to be a combination of food 
fortification and supplementation. Although the literature generally refers to food fortification as a 
highly cost-effective intervention, it is unlikely to cover the whole population, specifically those who 
do not regularly consume the fortified food (33). Combined strategies are more likely to meet cost-
effectiveness and coverage targets (33).   
Considering the low uptake of vitamin D supplements and the heterogeneity in food consumption 
among different population group, and similarly to what the literature reports for other 
micronutrients (33, 34), the preferred public health approach to improve the nutritional vitamin D 
status of the whole population is likely to be a combination of food fortification and supplementation 
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policies. Nonetheless, economic evaluations of combined interventions to prevent VDD have not yet 
been undertaken. We reiterate that stand-alone interventions may not be the most efficient strategy 
and highlight the importance of producing new economic evidence evaluating multi- interventions. 
 Clinical outcomes 
The most used clinical outcomes were fractures (n=8) (15, 17, 18, 20, 24, 26-28) and falls (n=5) (16, 
21-23, 25), although the evidence supporting such associations is controversial. The latest Cochrane 
reviews suggested that supplementation with vitamin D alone has no impact on risk of fractures (32) 
but may reduce the risk of falls in individuals with low vitamin D status at baseline, if a minimum of 
800 International Units (IU) per day is provided (35). The association of Vitamin D and calcium is 
likely to prevent a small number of hip and non-vertebral fractures in the elderly population (32).  
The choice of clinical outcome and the source of effectiveness data must be carefully considered and 
estimates tested in sensitivity analysis. For example, hip fractures have a great impact on morbidity, 
quality of life and mortality. They are also one of the costliest health outcomes in the elderly 
population. Therefore, risk reduction of hip fractures is likely to drive cost-effectiveness results (27).  
VDD has severe clinical consequences in children, namely rickets, which is associated with pain, 
deformities, muscle weakness, poor growth, hypocalcaemic seizures, tetany and heart disease and 
their sequelae, including death (8).  Despite their high prevalence in risk groups (11), these outcomes 
have not yet been picked up by health economics research. Effectiveness 
The effectiveness of supplementation programmes was largely sourced from clinical trials and meta-
analyses of clinical trials. Because clinical trials are conducted in controlled environments and 
generally have a short time frame, the recorded uptake rates are expected to be higher than those 
observed in real-life conditions. The World Health Organization (WHO) states that the uptake rate for 
chronic conditions is approximately 50% (36). Much lower rates, as low as 6%,  were reported for the 
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vitamin D supplements provided under the free supplementation scheme for infants in the UK (37). 
Therefore, economic evaluations assuming 100% uptake rate will overestimate the benefits of 
supplementation programmes. Further, we found that pooled estimates of the effect of vitamin D 
supplementation frequently included data from trials using vitamin D alone and vitamin D in 
combination with calcium (16, 17), makes it impossible to determine how much of the effect is 
attributable to vitamin D alone. 
The effectiveness of food fortification with vitamin D is an under-researched area and this may 
explain the paucity of economic evaluations of these strategies. The only study evaluating 
fortification programmes sourced effectiveness data of vitamin D and calcium from a Cochrane 
review using supplements (27). Several important parameters must be taken into account when 
considering the effectiveness and coverage of food fortification, such as the characteristics of the 
food vehicle and its bio-availability. The food vehicle needs to be accessible, ideally a staple food with 
a well-established consumption pattern within the targeted population (33). Moreover, chemical 
characteristics of both the nutrient and the food need to be considered to guarantee that the 
nutrient will be delivered in the desired amounts after food processing, package and storage.  Utilities 
The QALYs gained from the prevention of VDD were used in eight of the fourteen included studies 
(16, 19-24, 26). Utility measures were sourced from osteoporosis studies and used in economic 
evaluations of preventing falls (16, 21-23) and fractures (20, 24, 26). In studies focusing on falls 
prevention, fear of falling after a fall was an important cause of QALY decrement, in some cases 
having more impact on the quality of life of those who suffered a fall than fractures (38). 
Although attempts have been made to include QALY estimates for pregnant women and children 
(12), the authors were limited by the complete lack of evidence on the disutility of being vitamin D 
deficient beyond the falls and fractures related outcomes. 
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Costs and resources used 
The current literature is relatively homogenous in the methods used to cost programmes and how 
costs and resources used are reported. The studies focused on the healthcare sector, with great 
emphasis being given to the cost of purchasing vitamin D, either as a supplement or as a fortificant, 
and to treating clinical events related to VDD. However, micronutrient interventions are complex and 
their costs span across several public and private sectors. The current literature still treats these 
interventions as exclusively health programmes, providing limited information for policy makers.  
Previous research on vitamin A programmes showed that the main driver of the overall cost of the 
programme was staff costs in supplementation and the nutrient’s cost in food fortification 
programmes (33). Moreover, it highlighted the importance of accounting for information campaigns 
and staff training, without whom the effectiveness of the programmes is compromised.  Quality of the studies 
In general, studies adequately describe interventions compared, the outcome measures and 
satisfactory drew conclusions from the results reported. Nonetheless, the quality assessment 
highlighted poor reporting practices namely the lack of justification of the type of economic 
evaluation used, the choice of perspective and alternatives compared. Full results are presented in 
supplementary material and summarised in Table 3. It is possible that, because studies have been 
published in clinical journals, the authors have chosen to emphasise clinical aspects in detriment of 
analytical methods.  
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Conclusion 
Interventions to prevent VDD have been referred to in the literature as highly cost-effective and even 
cost-saving for some groups of the population. Nonetheless, the evidence shows several limitations 
that need to be addressed for a better understanding of what would be the most cost-effective 
approach to prevent VDD at a population level. This review found a lack of economic evaluations 
supporting population VDD prevention, and corroborates previous concerns about the underuse of 
economic evaluation to inform public health nutrition strategies (39, 40).  
Micronutrient deficiencies are effectively prevented through supplementation and food fortification 
programmes  and most countries have adopted a combination of both (33). None of the studies 
included in this review presented a direct comparison of the two strategies, neither considered a 
combined intervention of food fortification and supplementation. Therefore, it is not possible to 
conclude which intervention is the most cost-effective. The literature suggests that supplementation 
with  800 IU of vitamin D is likely to be cost-effective to prevent fractures and falls in older adults, 
especially for the elderly, high-risk population. Economic evaluations focusing on population-based 
interventions are needed, as well as sub-group analysis of other at-risk group such as infants, 
children, breastfeeding and pregnant women and individuals with darker skin. 
The literature on micronutrient programmes refers to food fortification as a highly cost-effective 
alternative to tackle deficiencies for its wide population coverage and low maintenance costs (33). 
Further research is needed to evaluate if the same applies to vitamin D interventions.  Acknowledgments 
This research was funded by the College of Medical and Dental Sciences of the University of 
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Table 1 Characteristics of the studies evaluating supplementation with vitamin D  
Study Population and setting Interventions 
Type of EE 
and method Perspective 
Time 
horizon 
Clinical 
outcome 
Measure of 
benefit Results 
Supplementation with vitamin D alone 
Frick et 
al. 2010 
(20) 
Community 
dwelling 
individuals 
over 65 
years. USA 
Vitamin D (800IU); Medical 
management of 
psychotropic drugs; Tai chi, 
Muscle and balance 
exercise; Home 
modifications multifactorial 
individualised programmes 
for all the population; 
Multifactorial 
individualised programmes 
for those with high risk of 
falling.  
Cost-utility. 
Base case 
incremental 
analysis 
Health Care 
Service 9 years 
Fall related 
hip fracture 
Cost per 
QALY 
Taking into account 
feasibility considerations, 
vitamin D 
supplementation and 
home modifications were 
the most cost-effective. 
Home modifications cost 
more $14,794 per QALY 
than vitamin D. 
Lee et al. 
2013 
(21) 
Community 
dwelling 
individuals 
age 65 to 80 
years. USA 
Population screening for 
VDD; Universal 
supplementation. After 
screening, VDD individuals 
were assumed to be 
supplemented with 1000IU 
of vitamin D if 25OHD was 
between 15–25 ng/mL and 
2000-4000IU if 25OHD<15 
ng/mL. 
Cost-utility. 
Markov 
model 
Payer 
perspective 3 years Falls 
Net 
Monetary 
Benefit using 
WTP of 
$50000/QAL
Y. 
Population screening was 
the preferred alternative 
for women (NMB 224$ 
for women and NMB 
$298 for men, when 
compared with universal 
supplementation (NMB 
189$ in women and NMB 
$260 in men). The benefit 
were more evident for 
the older group (80 years 
old): population 
screening had a NMB of 
$563 in women and $703 
in men, while universal 
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supplementation resulted 
in NMB of  $428 in 
women and $571 in men. 
Poole et 
al. 2014 
(17) 
Population 
over 65 
years. UK 
Vitamin D alone (800IU); 
Current care 
Cost-
effectiveness 
Markov 
model 
Health and 
Social Care  
Services 
1 year  Hip fracture 
Cost per 
avoided hip 
fracture 
Intervention was cost-
saving, with a net saving 
of £22M. For women 
aged 75-79 years, annual 
savings were 8.2M while 
for women aged 85 and 
over the savings were 
131M, due to increased 
incidence of hip fracture 
with age. 
Zarca et 
al 2014 
(24) 
Individuals 
over 65 
years. 
France 
Universal supplementation 
with high-dose Vitamin D; 
Universal supplementation 
followed by 25OHD test 
(after 3 months); 25OHD 
test followed by treating 
those VDD; No 
intervention. 
Cost-utility 
analysis 
Health Care 
Service Lifetime 
 Hip 
fracture 
Cost per 
QALY 
Universal 
supplementation with 
high-dose Vitamin D was 
dominated by the both 
interventions Universal 
supplementation 
followed by 25OHD test 
(€5.219/QALY) and 
25OHD test followed by 
treating those VDD   
(€9.104/QALY).    
Filby et 
al. 2014 
(18) 
Pregnant 
and 
breastfeedin
g women, 
children 
aged less 
than 5 years, 
adults over 
65 years, 
Universal provision of 
vitamin D; 25OHD test 
followed by treatment 
Cost-
consequence  
analysis 
Health Care 
Service 1 year - 
Cost per 
extra person 
taking 
supplements 
and cost per 
averted case 
of VDD 
Universal 
supplementation was 
cost-saving in comparison 
with testing the whole 
population. Incremental 
cost of testing women, 
children, people aged 
over 65y and dark 
skinned sub-group was 
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dark skinned 
population. 
UK 
£10 million, £21 million, 
£25 million and £160 
million, respectively. 
Poole et 
al. 2015 
(16) 
Individuals 
over 60 
years. UK 
Vitamin D alone (800IU); 
Current care 
Cost-utility 
analysis. 
Markov 
model 
National 
health and 
social care  
services 
5 years  Falls Cost per QALY 
Supplementation for 
those aged over 60 years 
had an ICER of 
£19,759/QALY. 
Supplementing those 
aged over 65 years 
dominated current care 
by being cost-saving and 
leading to increased 
QALYs. 
Church 
et al. 
2015 
(23) 
Elderly 
population 
(over 84 
years) living 
in residential 
care 
facilities. 
Australia 
Vitamin D supplementation 
(800IU); Medication 
review; Multifactorial 
intervention. Each was 
compared against the ‘no 
intervention’ scenario. 
Cost-utility 
analysis. 
Markov 
model 
Health care 
Service Lifetime  Falls 
Cost per 
QALY.  
Vitamin D 
supplementation and 
medication review were 
both cost-saving, 
compared to ‘no 
intervention’. ICER for 
medication review 
relative to vitamin D 
supplementation was 
AU$2442/QALY. 
Patil et 
al. 2016 
(25) 
Home 
dwelling 
elderly 
women aged 
between 70-
80 years. 
Finland 
Vitamin D (800IU); Vitamin 
D (800IU) + exercise; 
Exercise alone. 
Cost-
effectiveness 
Trial-based 
analysis 
 Societal 2 years 
Medically 
assisted 
falls 
Medically 
attended 
injurious falls 
per person 
year 
Supplementation with 
vitamin D alone was 
dominated and excluded 
from analysis. ICERs of 
€221 for no intervention, 
€708 for exercise only 
and €3820 for vitamin D 
and exercise.  
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Supplementation with vitamin D in association with calcium or other nutrients 
Study Population and setting Interventions 
Type of EE 
and method Perspective 
Time 
horizon 
Clinical 
outcome 
Measure of 
benefit Results 
Togerson 
et al.  
1995 
(15) 
Elderly 
Women (i) 
living  in the 
community 
(ii) in 
nursing 
homes, (iii) 
with low 
BMI in 
nursing 
homes. UK 
Oral supplementation  with 
vitamin D (800IU) and 
calcium  (1.2g); Annual 
parenteral vitamin D  
(300,000IU)  
Cost-
effectiveness
. Trial-based 
analysis 
National 
Health Service 3 years  Fractures  
Cost per 
averted 
fracture (all 
fractures and 
hip fracture) 
For women living in the 
community, the cost per 
averted fracture with 
parenteral vitamin D was 
£946 for all fractures 
and£ £2,317 for hip 
fractures. With oral 
supplements, the cost per 
averted fracture was 
14,420£ and 22,379£ for 
hip fractures. Targeting to 
those with low BMI and 
those in nursing homes 
reduced the costs. 
Willis et 
al. 2002 
(26) 
Women 
aged 
between 50-
90 years. 
Sweden 
Supplementation with 
vitamin D (800IU( and 
calcium  (1.2g); no 
intervention 
Cost-utility. 
Markov 
model 
National 
Health and 
Social Welfare 
Service 
Until 
patients 
were 90 
years old 
 Hip 
fractures 
Cost per 
QALY 
Intervention was cost-
saving for those aged 70 
years. Intervention was 
cost-effective (SEK 
7,740/QALY) for younger 
women at high risk of hip-
fractures. 
Lilliu et 
al.  2003 
(28) 
Elderly 
women in 
nursing 
homes 
Belgium, 
France, 
Germany, 
Netherlands, 
Spain, 
Supplementation with 
vitamin D (800IU( and 
calcium  (1.2g); no 
intervention 
Cost-
effectiveness
. Trial based 
analysis  
National 
Health Care 
Service 
3 years  Hip fractures 
Cost per 
avoided hip 
fracture 
Costs in placebo group 
were higher for all 
countries. Overall, the net 
benefit ranged between 
£79,000 and £711,000 
per 1000 women. 
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Sweden, and 
the UK. 
Church 
et al. 
2011 
(22) 
Individuals 
over 65 
years living 
in the 
community 
and in 
residential 
care. 
Australia 
Community dwelling: Tai-
chi; Home hazard 
assessment; Exercise, 
multiple interventions; 
Cataract surgery; 
Psychotropic medication 
withdrawal; Cardiac pacing. 
Residential care: Hip 
protectors; 
Supplementation with 
vitamin D and calcium; 
Multiple interventions; 
Medical reviews. 
Cost-utility 
and cost-
effectiveness
. Markov 
model 
National 
Health Care 
Service 
(authors state 
a societal 
perspective 
when 
possible) 
10 years  Falls Cost per QALY 
Community dwelling: 
Most cost-effective were 
Tai chi, home hazard 
assessment and group 
exercise. Residential care: 
The most cost-effective 
intervention was 
medication review, 
followed by 
supplementation with 
vitamin D and calcium. 
Filby et 
al. 2015 
(19) 
Pregnant 
women, 
women 
planning to 
become 
mothers, 
infants, and 
young 
children. UK 
Vitamin D provided in a 
multivitamin preparation. 
Scenario 1: Current 
targeted supplementation 
based on income; Universal 
supplementation (no 
income restrictions). 
Scenario 2: Universal 
supplementation 
(extended to all women 
planning a pregnancy, and 
children between 4-5 
years); current targeted 
supplementation based on 
income. 
Cost-
effectiveness 
and cost-
utility. Base 
case 
incremental 
analysis. 
Public sector 
(local 
authority, 
central 
government 
and the 
National 
Heath Care 
Service)  and 
societal 
Lifetime 
Pregnancy 
affected by 
a neural 
tube 
defects, 
symptomat
ic vitamin D 
deficiency 
or LRNI for 
vitamin A 
and C in 
each 
subgroup 
Cost per 
QALY 
Scenario 1: universal 
offering scheme was not 
cost-effective, ICER of 
£620,898. Universal 
scheme in scenario 2 was 
likely to be cost-effective 
effective for any 
subgroup combinations 
that includes ‘women 
planning a pregnancy and 
before 10 weeks 
pregnant’, ICER of £6,528.  
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NC – not clear; EE – Economic Evaluation; WTP – Willingness to pay; NMB –Net Monetary Benefit; M – Million;  ICER – Incremental Cost Effectiveness 
Ratio; AU – Australian Dollars BMI – Body Mass Index; LRNI – Lower Reference Nutrient Intake;  
 
Table 2 Characteristics of the studies evaluating supplementation with multi-vitamin supplements 
Characteristics of included studies 
Study 
Population 
and setting 
Interventions 
Type of EE and 
method 
Perspective 
Time 
horizon 
Clinical 
outcome 
Measure of 
benefit 
Results 
Sandmann 
et al. 2015 
(27) 
Women 
over 65 
years. 
Germany 
Bread fortification 
with vitamin D 
(800IU) + calcium 
(200mg); No food 
fortification. 
Cost-
effectiveness 
Analytic model 
(not specified) 
 Societal 10 years 
and 35 
years 
Fractures Cost per 
avoided 
fracture 
Bread fortification with vitamin D 
and calcium was cost saving 
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Table 3 Summary of the results  
Study ID Intervention Population  Result Quality/comments  
Sandmann et 
al. 2015 (27) 
Bread fortification with vitamin D 
(800IU) + calcium (200mg) 
Elderly (+65 years) Bread fortification was cost-
saving 
Adequate 
Zarca et al 
2014 (24) 
Population screening vs. 
Universal supplementation with 
vitamin D  
Elderly (+65 years) Screening was the most cost-
effective 
Adequate 
Filby et al. 
2014 (18) 
Population screening vs. 
Universal supplementation with 
vitamin D  
Pregnant and 
breastfeeding women, 
children (< 5 years), elderly 
(+ 65 years) and dark 
skinned. 
Universal supplementation was 
cost-saving 
Good 
Lee et al. 2013 
(21) 
Population screening vs. 
Universal supplementation with 
vitamin D  
Elderly (+65 years) Screening was the most cost-
effective alternative 
Inadequate 
Patil et al. 
2016 (25) 
Supplementation with vitamin D  
(800IU) alone vs. 
Supplementation with vitamin D 
(800IU) and Exercise vs. Exercise 
alone 
Elderly (+65 years) Supplementation (800IU) alone 
was dominated. Exercise alone 
was the most cost-effective 
Adequate 
Poole et al. 
2014 (17) 
Supplementation with vitamin D  
(800IU) vs. Current practice 
Elderly (65-80 years) Supplementation (800IU) was 
cost-saving 
Adequate 
Church et al. 
2015 (23) 
Supplementation with vitamin D 
(800IU) 
Elderly  (+84 years; nursing 
homes) 
Supplementation (800IU) was 
cost-saving 
Adequate 
Togerson et al.  
1995 (15) 
Supplementation with vitamin D 
(800IU) and calcium  (1.2g) vs. 
Annual parenteral with  vitamin D  
(300,000IU) 
Elderly (+65 years; women) Annual parenteral with  vitamin D  
(300,000IU) was the most cost-
effective 
Inadequate 
Willis et al. 
2002 (26) 
Supplementation with vitamin D 
(800IU) and calcium  (1.2g) vs. No 
intervention 
Elderly ( 50-90 year; 
women) 
Intervention was cost-saving (>70 
years) and cost-effective (50-70 
years) 
Adequate 
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Lilliu et al.  
2003 (28) 
Supplementation with vitamin D 
(800IU) and calcium (1.2g) vs. No 
intervention 
Elderly (+65 years; women) Country-dependent. Costs in 
placebo group higher than in 
intervention arm 
Adequate 
Church et al. 
2011 (22) 
Supplementation with vitamin D 
(800IU) and calcium  (1.2g) vs. No 
intervention 
Elderly (+65 years) Supplementation with vitamin D 
and calcium was  cost-effective 
Good 
Frick et al. 
2010 (20) 
Supplementation with vitamin D 
(800IU) vs. No intervention 
Elderly (+65 years) Supplementation (800IU) was 
cost-effective 
Adequate 
Poole et al. 
2015 (16) 
Supplementation with vitamin D 
(800IU) vs. No intervention 
Elderly (+65 years) Supplementation (800IU)  was 
cost-effective (cost-saving for the 
older cohorts) 
Adequate 
Filby et al. 
2015 (19) 
Universal supplementation with 
vitamin D (multi-vitamin 
preparation) vs. Targeted 
supplementation based on 
income status 
Pregnant women, women 
planning pregnancy, infants 
and young children 
Universal supplementation was 
cost-effective for women 
pregnant women and women 
planning pregnancy only 
Adequate 
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